Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This review discusses the evidence for using oral medications to treat central serous chorioretinopathy, highlighting eplerenone as having the most support despite a lack of robust efficacy across studies.

This review discusses sex-specific cosmetic treatment recommendations using lasers and energy-based devices for male patients and reports no new clinical findings, highlighting the need for tailored approaches for common male concerns.

This paper discusses a structure-based analysis to find new BRD4 inhibitors, identifying finasteride and amentoflavone as promising candidates for BET inhibition.

This review summarizes existing clinical guidelines for hormonal therapy in gender dysphoria, observing similarities in international practices and emphasizing the need for more evidence-based research, particularly on GnRH agonists for both trans women and men.

This paper argues that trademark use theory is flawed and should be abandoned in favor of a contextual analysis approach to better address trademark disputes and lawmaking.

This report describes a rare case of alopecia areata universalis developing in a child during the recovery phase of phenobarbital-induced anti-convulsant hypersensitivity syndrome, which suggests a mechanism involving lymphocyte-related immune responses.

Public interest in COVID-19-related hair loss increased during COVID-19 surges, especially with the omicron variant.

This review covers clinical studies on using homoeopathy to treat PCOS and concludes that further rigorous research is necessary to substantiate its effectiveness.

Finasteride for female hair loss has low side effects, more research needed.

This study reviewed the safety of JAK inhibitors for alopecia areata, finding that common side effects included headache and acne, with varying risks for respiratory infections and no increased risk of serious adverse events.

This review discusses treatment options for hair loss in women and reports no new clinical results; it highlights minoxidil as the only drug proven to effectively improve alopecia based on rigorous studies.

Natural products like saw palmetto, caffeine, melatonin, marine extracts, rosemary oil, procyanidin, pumpkin seed oil, and cannabidiol oil could potentially treat male hair loss.

This review explores keyword advertising in online advertising, noting its appeal due to audience reach and campaign optimization, but reports no new research data.

This study found that public interest in "COVID hair loss," "telogen effluvium," and "hair loss" increased in the U.S. since mid-March, particularly in states with early COVID-19 case surges.

Hair loss is more common in summer and fall.

This article highlights the rising interest in Janus kinase inhibitors for alopecia areata, especially following the FDA approval of baricitinib, underscoring the need for better patient education and physician guidance in selecting appropriate treatments for hair loss.

This study analyzed Google Trends data from 2018 to 2023, revealing an increasing global interest in hair loss treatments, particularly for "oral minoxidil" and "dutasteride," though interest varies by region and treatment type.

This study observed that public interest in JAK-inhibitor treatments for alopecia areata significantly increased around the FDA approval in 2022 and heightened media coverage, suggesting an important role for patient education about these treatments.

This study observed that many individuals with alopecia areata seek or receive dietary and nutritional advice to manage their condition, often making changes such as taking supplements or adding specific foods, yet most reported no change in their disease status.

This study found that while the over-the-counter market for minoxidil hair loss products is expanding, only 25% of these products report safety information, and none report adverse effects, highlighting a need for greater transparency and accuracy in their advertising.

This review discusses the potential effectiveness and regenerative promise of Platelet-Rich Plasma in treating cicatricial alopecia, while emphasizing the need for standardized research methods and further studies.

This literature review reports that treatments for alopecia areata, including topical and intralesional corticosteroids, provide varied responses, and emphasizes the importance of supporting patients emotionally, given the limited and promising evidence of effectiveness for other treatments.

In this study, researchers evaluated online resources for psychological support for alopecia areata patients and found the quality lacking, with most resources not providing adequate advice or referring to therapies like cognitive behavioral therapy, despite the significant psychological impact of the condition.

This review analyzes granted patents for skin bioinks for 3D skin bioprinting from 2017 to 2022 and reports no new clinical results.

Interest in COVID-19 hair loss increased during COVID-19 surges, especially in higher-income countries.

This review reports the first known case of hair repigmentation associated with lamivudine use and examines mechanisms related to drug-induced hair repigmentation, suggesting potential therapeutic strategies for reversing hair graying.

The document plans to assess if Xiao-Chai-Hu-Tang is effective for chronic fatigue syndrome but has no results yet.

This research review concluded that 5α-reductase inhibitors may be effective in treating androgenetic alopecia, showing general efficacy over placebo, though future clinical trials are needed to determine the best drug, dose, and duration, as well as gender differences in treatment response.

This review examines the occurrence of permanent alopecia associated with docetaxel in breast cancer treatment, identifying a reported case of lasting hair loss in one patient.

This study reports no clinical results; it examined U.S. plastic surgery websites for promotion of cosmetic procedures targeting males.